Nick Clare, Vendor Strategy Work Group leader at ELRIG UK and regional sales manager at Synthego said: “I appreciate the quality of science available through ELRIG; it is free to access and enables us all to grow together. I want to bring a stronger voice on behalf of the vendor by helping them to provide their expertise and share different ways of thinking about science, while continuing to support ELRIG’s events. The more we collaborate with the vendors, the more we can enable the drug discovery community to progress therapeutic candidates through to the clinic.”
Melanie Leveridge, chair of ELRIG UK, and head of Screening, Profiling and Mechanistic Biology, and Global Compound Management at GSK, said: “Nick’s experience, both in his day job at Synthego and from his involvement with our Networking Work Group, make him an excellent candidate to take on this role. With his help, we aim to better align ELRIG’s strategy with the needs of the vendor community, and ensure our scientific programme is well-connected with the exhibitors at our events.”
For more information about the ELRIG board, please visit:
www.elrig.org/about/governance/the-board/ About ELRIG UK The European Laboratory Research & Innovation Group (ELRIG) is a leading European not-for-profit organisation that exists to provide outstanding scientific content to the life science community. Our values are to always ensure the highest quality of content and that content will be made readily accessible to all, and that we will always be an inclusive organisation, serving a diverse scientific network. In addition, ELRIG will always be a volunteer led organisation, run by and for the life sciences community. Visit:
www.elrig.org.